Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning

We describe here a new method for predicting class II major histocompatibility complex-binding peptides, based on the preferences observed in a systematic series of peptide binding experiments where each position in a "minimal" peptide was replaced individually by every amino acid. The DRB1*0401 peptide binding preferences were determined and incorporated into a computer program that looks through sequences for potential epitopes and assigns each a score. These scores correlate well with previously determined T cell epitopes of foreign antigens and endogenous peptides from self proteins. Our findings hold implications for the design of subunit vaccines and in the identification of autoantigenic peptide regions within self proteins.

[1]  D. Wiley,et al.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.

[2]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[3]  F. Sinigaglia,et al.  Selection of T cell epitopes and vaccine engineering. , 1991, Methods in enzymology.

[4]  F. Sinigaglia,et al.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries , 1992, The Journal of experimental medicine.

[5]  J L Cornette,et al.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence. , 1987, Journal of immunology.

[6]  J. Rothbard,et al.  Conformational and structural characteristics of peptides binding to HLA-DR molecules. , 1991, Journal of immunology.

[7]  J. Woody,et al.  Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin , 1982, Nature.

[8]  M F del Guercio,et al.  HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.

[9]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[10]  H. Grey,et al.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Todd,et al.  A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.

[12]  D. Wiley,et al.  Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. , 1990, The EMBO journal.

[13]  M. Davis,et al.  Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). , 1994, Journal of immunology.

[14]  L. Kappos,et al.  Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. , 1993, The Journal of clinical investigation.

[15]  F. Sinigaglia,et al.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.

[16]  H. Erlich,et al.  MHC class-II molecules and autoimmunity. , 1991, Annual review of immunology.

[17]  Eric O Long,et al.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis , 1991, The Journal of experimental medicine.

[18]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[19]  W. Taylor,et al.  A sequence pattern common to T cell epitopes. , 1988, The EMBO journal.